NTRB Logo.png
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
07 févr. 2025 08h45 HE | Nutriband Inc.
U.S. Patent Office issues Notice of Allowance for new patent covering Nutriband's AVERSA™ technology
Full Logo - OKYO .jpg
OKYO Pharma to Complete Enrollment of Neuropathic Corneal Pain Trial by End of Second Quarter
29 janv. 2025 08h00 HE | OKYO Pharma LTD
LONDON and NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic...
Logo.png
PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor
27 janv. 2025 09h29 HE | PetVivo Holdings, Inc.
PetVivo Board Appoints Eldred as Executive Director to Lead Company Product Commercialization and Operations MINNEAPOLIS, MN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV,...
Full Logo - OKYO .jpg
OKYO Pharma Receives $1.4 Million in Non-Dilutive Funding
22 janv. 2025 07h00 HE | OKYO Pharma LTD
LONDON and NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic...
Green and Gray.png
Dogwood Therapeutics Announces Patient Dosing in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy Induced Neuropathy (CINP) to Commence First Quarter of 2025
21 janv. 2025 09h15 HE | Dogwood Therapeutics, Inc.
ATLANTA, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on advancing first-in class, non-opioid,...
Logo.png
PetVivo to Exhibit Spryng with OsteoCushion™ Technology at the Veterinary Meeting and Expo Conference in Orlando, Florida on January 25-29, 2025
14 janv. 2025 09h29 HE | PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Jan. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading provider of medical devices and biomedical therapeutics for equines and companion animals...
Logo.png
PETVIVO HOLDING, INC. ANNOUNCES PARTNERSHIP ENGAGEMENTS WITH VEDCO, INC. AND CLIPPER DISTRIBUTING, LLC
10 janv. 2025 09h45 HE | PetVivo Holdings, Inc.
MINNEAPOLIS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV & PETVW) ("PetVivo"), a pioneering biomedical technology company focused on adapting human biotech, medical...
NTRB Logo.png
Nutriband Issues Letter to Shareholders
31 déc. 2024 07h00 HE | Nutriband Inc.
CEO Publishes Letter to Shareholders looking over achievements in 2024 and outlook for 2025
Logo.png
PETVIVO HOLDINGS, INC. TO HOST SHAREHOLDERS UPDATE MEETING ON JANUARY 8, 2025
30 déc. 2024 10h23 HE | PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Dec. 30, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical...
NTRB Logo.png
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
27 déc. 2024 09h25 HE | Nutriband Inc.
Chinese Patent for AVERSA extended to Macao